Back
VAALCO Energy 10K Form
Buy
67
EGY
VAALCO Energy
Last Price:
6.32
Seasonality Move:
13.38%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-08 | 10Q | EGY/VAALCO Energy Quarterly |
2023-11-08 | 10Q | EGY/VAALCO Energy Quarterly |
2023-08-09 | 10Q | EGY/VAALCO Energy Quarterly |
2023-05-10 | 10Q | EGY/VAALCO Energy Quarterly |
2022-11-08 | 10Q | EGY/VAALCO Energy Quarterly |
2022-08-10 | 10Q | EGY/VAALCO Energy Quarterly |
Receive EGY News And Ratings
See the #1 stock for the next 7 days that we like better than EGY
EGY Financial Statistics
Sales & Book Value
Annual Sales: | $455.07M |
---|---|
Cash Flow: | $5.21M |
Price / Cash Flow: | 5.55 |
Annual Sales: | $4.57 |
Price / Book: | 1.35 |
Profitability
EPS (TTM): | 0.60000 |
---|---|
Net Income (TTM): | $64.57M |
Gross Margin: | $186.61M |
Return on Equity: | 14.02% |
Return on Assets: | 7.85% |
VAALCO Energy Earnings Forecast
Key VAALCO Energy Financial Ratios
- The Gross Profit Margin over the past 34 years for EGY is 41.01%.
- The Selling, General & Administrative Expenses for EGY have been equal to 5.24% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 3.92% of Operating Income.
- The Net Earning history of EGY is 13.26% of Total Revenues.
- Per Share Earnings over the last 34 years have been positive in 20 years.
VAALCO Energy Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Oil, Gas & Consumable Fuels |
Sector: | Energy |
Current Symbol: | EGY |
CUSIP: | 91851C |
Website: | vaalco.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 1.66 |
Quick Ratio: | 1.55 |
Price-to-Earnings
Trailing P/E Ratio: | 10.98 |
---|---|
Forward P/E Ratio: | 15 |
EGY Technical Analysis vs Fundamental Analysis
Buy
67
VAALCO Energy (EGY)
is a Buy
Is VAALCO Energy a Buy or a Sell?
-
VAALCO Energy stock is rated a Buy
The current VAALCO Energy [EGY] share price is $6.15. The Score for EGY is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.